Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 146 Pages
Report ld: 6549714
Request Sample
Customized Report
The global Blasticidin S market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blasticidin S competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
The North American market for Blasticidin S is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Blasticidin S is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Blasticidin S include Merck, Santa Cruz Biotechnology, Selleck Chemicals, Adooq Bioscience, Carl Roth, Bio-Techne, Enzo Biochem, Abcam, BioVision, APExBIO Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Blasticidin S market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blasticidin S. The Blasticidin S market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blasticidin S market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blasticidin S manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blasticidin S manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Blasticidin S production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Blasticidin S consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Blasticidin S Market Overview
1.1 Product Definition
1.2 Blasticidin S by Type
1.2.1 Global Blasticidin S Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Blasticidin S by Application
1.3.1 Global Blasticidin S Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Blasticidin S Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Blasticidin S Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Blasticidin S Production Estimates and Forecasts (2021–2032)
1.4.4 Global Blasticidin S Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Blasticidin S Production Market Share by Manufacturers (2021–2026)
2.2 Global Blasticidin S Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Blasticidin S, Industry Ranking, 2024 vs 2025
2.4 Global Blasticidin S Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Blasticidin S Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Blasticidin S, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Blasticidin S, Product Offerings and Applications
2.8 Global Key Manufacturers of Blasticidin S, Date of Entry into the Industry
2.9 Blasticidin S Market Competitive Situation and Trends
2.9.1 Blasticidin S Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Blasticidin S Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Blasticidin S Production by Region
3.1 Global Blasticidin S Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Blasticidin S Production Value by Region (2021–2032)
3.2.1 Global Blasticidin S Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Blasticidin S by Region (2027–2032)
3.3 Global Blasticidin S Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Blasticidin S Production Volume by Region (2021–2032)
3.4.1 Global Blasticidin S Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Blasticidin S by Region (2027–2032)
3.5 Global Blasticidin S Market Price Analysis by Region (2021–2032)
3.6 Global Blasticidin S Production, Value, and Year-over-Year Growth
3.6.1 North America Blasticidin S Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Blasticidin S Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Blasticidin S Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Blasticidin S Production Value Estimates and Forecasts (2021–2032)
4 Blasticidin S Consumption by Region
4.1 Global Blasticidin S Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Blasticidin S Consumption by Region (2021–2032)
4.2.1 Global Blasticidin S Consumption by Region (2021–2026)
4.2.2 Global Blasticidin S Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Blasticidin S Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Blasticidin S Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Blasticidin S Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Blasticidin S Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Blasticidin S Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Blasticidin S Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Blasticidin S Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Blasticidin S Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Blasticidin S Production by Type (2021–2032)
5.1.1 Global Blasticidin S Production by Type (2021–2026)
5.1.2 Global Blasticidin S Production by Type (2027–2032)
5.1.3 Global Blasticidin S Production Market Share by Type (2021–2032)
5.2 Global Blasticidin S Production Value by Type (2021–2032)
5.2.1 Global Blasticidin S Production Value by Type (2021–2026)
5.2.2 Global Blasticidin S Production Value by Type (2027–2032)
5.2.3 Global Blasticidin S Production Value Market Share by Type (2021–2032)
5.3 Global Blasticidin S Price by Type (2021–2032)
6 Segment by Application
6.1 Global Blasticidin S Production by Application (2021–2032)
6.1.1 Global Blasticidin S Production by Application (2021–2026)
6.1.2 Global Blasticidin S Production by Application (2027–2032)
6.1.3 Global Blasticidin S Production Market Share by Application (2021–2032)
6.2 Global Blasticidin S Production Value by Application (2021–2032)
6.2.1 Global Blasticidin S Production Value by Application (2021–2026)
6.2.2 Global Blasticidin S Production Value by Application (2027–2032)
6.2.3 Global Blasticidin S Production Value Market Share by Application (2021–2032)
6.3 Global Blasticidin S Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Merck
7.1.1 Merck Blasticidin S Company Information
7.1.2 Merck Blasticidin S Product Portfolio
7.1.3 Merck Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Merck Main Business and Markets Served
7.1.5 Merck Recent Developments/Updates
7.2 Santa Cruz Biotechnology
7.2.1 Santa Cruz Biotechnology Blasticidin S Company Information
7.2.2 Santa Cruz Biotechnology Blasticidin S Product Portfolio
7.2.3 Santa Cruz Biotechnology Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Santa Cruz Biotechnology Main Business and Markets Served
7.2.5 Santa Cruz Biotechnology Recent Developments/Updates
7.3 Selleck Chemicals
7.3.1 Selleck Chemicals Blasticidin S Company Information
7.3.2 Selleck Chemicals Blasticidin S Product Portfolio
7.3.3 Selleck Chemicals Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Selleck Chemicals Main Business and Markets Served
7.3.5 Selleck Chemicals Recent Developments/Updates
7.4 Adooq Bioscience
7.4.1 Adooq Bioscience Blasticidin S Company Information
7.4.2 Adooq Bioscience Blasticidin S Product Portfolio
7.4.3 Adooq Bioscience Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Adooq Bioscience Main Business and Markets Served
7.4.5 Adooq Bioscience Recent Developments/Updates
7.5 Carl Roth
7.5.1 Carl Roth Blasticidin S Company Information
7.5.2 Carl Roth Blasticidin S Product Portfolio
7.5.3 Carl Roth Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Carl Roth Main Business and Markets Served
7.5.5 Carl Roth Recent Developments/Updates
7.6 Bio-Techne
7.6.1 Bio-Techne Blasticidin S Company Information
7.6.2 Bio-Techne Blasticidin S Product Portfolio
7.6.3 Bio-Techne Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Bio-Techne Main Business and Markets Served
7.6.5 Bio-Techne Recent Developments/Updates
7.7 Enzo Biochem
7.7.1 Enzo Biochem Blasticidin S Company Information
7.7.2 Enzo Biochem Blasticidin S Product Portfolio
7.7.3 Enzo Biochem Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Enzo Biochem Main Business and Markets Served
7.7.5 Enzo Biochem Recent Developments/Updates
7.8 Abcam
7.8.1 Abcam Blasticidin S Company Information
7.8.2 Abcam Blasticidin S Product Portfolio
7.8.3 Abcam Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Abcam Main Business and Markets Served
7.8.5 Abcam Recent Developments/Updates
7.9 BioVision
7.9.1 BioVision Blasticidin S Company Information
7.9.2 BioVision Blasticidin S Product Portfolio
7.9.3 BioVision Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 BioVision Main Business and Markets Served
7.9.5 BioVision Recent Developments/Updates
7.10 APExBIO Technology
7.10.1 APExBIO Technology Blasticidin S Company Information
7.10.2 APExBIO Technology Blasticidin S Product Portfolio
7.10.3 APExBIO Technology Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 APExBIO Technology Main Business and Markets Served
7.10.5 APExBIO Technology Recent Developments/Updates
7.11 Cayman Chemical
7.11.1 Cayman Chemical Blasticidin S Company Information
7.11.2 Cayman Chemical Blasticidin S Product Portfolio
7.11.3 Cayman Chemical Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Cayman Chemical Main Business and Markets Served
7.11.5 Cayman Chemical Recent Developments/Updates
7.12 Focus Biomolecules
7.12.1 Focus Biomolecules Blasticidin S Company Information
7.12.2 Focus Biomolecules Blasticidin S Product Portfolio
7.12.3 Focus Biomolecules Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Focus Biomolecules Main Business and Markets Served
7.12.5 Focus Biomolecules Recent Developments/Updates
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Blasticidin S Company Information
7.13.2 Thermo Fisher Scientific Blasticidin S Product Portfolio
7.13.3 Thermo Fisher Scientific Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Thermo Fisher Scientific Main Business and Markets Served
7.13.5 Thermo Fisher Scientific Recent Developments/Updates
7.14 MyBiosource
7.14.1 MyBiosource Blasticidin S Company Information
7.14.2 MyBiosource Blasticidin S Product Portfolio
7.14.3 MyBiosource Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 MyBiosource Main Business and Markets Served
7.14.5 MyBiosource Recent Developments/Updates
7.15 InvivoGen
7.15.1 InvivoGen Blasticidin S Company Information
7.15.2 InvivoGen Blasticidin S Product Portfolio
7.15.3 InvivoGen Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 InvivoGen Main Business and Markets Served
7.15.5 InvivoGen Recent Developments/Updates
7.16 Gold Biotechnology
7.16.1 Gold Biotechnology Blasticidin S Company Information
7.16.2 Gold Biotechnology Blasticidin S Product Portfolio
7.16.3 Gold Biotechnology Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Gold Biotechnology Main Business and Markets Served
7.16.5 Gold Biotechnology Recent Developments/Updates
7.17 Beyotime
7.17.1 Beyotime Blasticidin S Company Information
7.17.2 Beyotime Blasticidin S Product Portfolio
7.17.3 Beyotime Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 Beyotime Main Business and Markets Served
7.17.5 Beyotime Recent Developments/Updates
7.18 TOKU-E
7.18.1 TOKU-E Blasticidin S Company Information
7.18.2 TOKU-E Blasticidin S Product Portfolio
7.18.3 TOKU-E Blasticidin S Production, Value, Price, and Gross Margin (2021–2026)
7.18.4 TOKU-E Main Business and Markets Served
7.18.5 TOKU-E Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Blasticidin S Industry Chain Analysis
8.2 Blasticidin S Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Blasticidin S Production Modes and Processes
8.4 Blasticidin S Sales and Marketing
8.4.1 Blasticidin S Sales Channels
8.4.2 Blasticidin S Distributors
8.5 Blasticidin S Customer Analysis
9 Blasticidin S Market Dynamics
9.1 Blasticidin S Industry Trends
9.2 Blasticidin S Market Drivers
9.3 Blasticidin S Market Challenges
9.4 Blasticidin S Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Blasticidin S was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 151
USD 3950.00
(Single User License)
The global Blasticidin S market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 177
USD 4900.00
(Single User License)
The global market for Blasticidin S was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 150
USD 3950.00
(Single User License)
The global market for Blasticidin S was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 111
USD 2900.00
(Single User License)
The global Blasticidin S market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 102
USD 4250.00
(Single User License)
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published Date: 2024-04-07
Pages: 114
USD 4900.00
(Single User License)
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published Date: 2024-02-19
Pages: 137
USD 3950.00
(Single User License)
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published Date: 2024-01-12
Pages: 112
USD 2900.00
(Single User License)
The global market for Blasticidin S was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 151
The global Blasticidin S market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 177
The global market for Blasticidin S was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 150
The global market for Blasticidin S was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 111
The global Blasticidin S market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 102
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published: 2024-04-07
Pages: 114
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published: 2024-02-19
Pages: 137
Blasticidin S is a peptide nucleoside antibiotic that is used as a selection agent for transformed cells that contain the resistance genes bls, bsr, or BSD. It specifically inhibits protein synthesis in both prokaryotes and eukaryotes by interfering with the peptide bound formation in the ribosomal machinery.
Published: 2024-01-12
Pages: 112
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now